Forma Therapeutics Series C Preferred Stock Financing
In 2012, a team of lawyers in Boston represented Forma Therapeutics in the Series C1 Preferred Stock financing in portfolio tracking shares to Lilly Ventures and Novartis Bioventures. Forma Therapeutics Is a Cambridge, Massachusetts-based biopharmaceutical company.
Posted on August 29, 2012
Disclaimer
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.